Package Leaflet: Information for the Patient
Daxas 250micrograms tablets
roflumilast
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Daxas contains the active substance roflumilast, which is a phosphodiesterase-4 inhibitor anti-inflammatory. Roflumilast reduces the activity of phosphodiesterase-4, a protein that occurs naturally in the body's cells. When the activity of this protein is reduced, inflammation in the lungs decreases. This helps to stop the narrowing of the airways that occurs in chronic obstructive pulmonary disease (COPD). Therefore, Daxas relieves respiratory problems.
Daxas is used for the maintenance treatment of severe COPD in adults who have had frequent worsening of their COPD symptoms (exacerbations) in the past and who have chronic bronchitis. COPD is a chronic lung disease that results in the narrowing of the airways (obstruction) and swelling and irritation of the walls of the small airways in the lungs (inflammation). This leads to symptoms such as coughing, wheezing, chest tightness, or difficulty breathing. Daxas should be used in combination with bronchodilators.
Do not take Daxas
- if you are allergic to roflumilast or any of the other ingredients of this medicine (listed in section 6)
- if you have moderate or severe liver problems.
Warnings and precautions
Consult your doctor or pharmacist before starting treatment with Daxas.
Sudden episodes of shortness of breath (dyspnea)
Daxas is not indicated for the treatment of acute bronchospasm (sudden episodes of shortness of breath). To relieve a sudden episode of shortness of breath, it is very important that your doctor provides you with another medicine that you will have available at all times to overcome such episodes. Daxas will not help you in these situations.
Body weight
You should check your weight periodically. Consult your doctor if, while taking this medicine, you notice an unintentional weight loss (not due to diet or exercise).
Other diseases
Daxas is not recommended if you have one or more of the following diseases:
There is limited experience with Daxas in these diseases. If you are diagnosed with any of these diseases, consult your doctor.
Experience with the use of Daxas in patients with a previous diagnosis of tuberculosis, viral hepatitis, viral herpes, or herpes zoster is also limited. Consult your doctor if you have any of these diseases.
Symptoms you should be aware of
During the first few weeks of treatment with Daxas, you may experience diarrhea, nausea, abdominal pain, or headache. If these side effects do not disappear after the first few weeks of treatment, consult your doctor.
Daxas is not recommended in patients with a history of depression associated with suicidal ideation or behavior. You may also experience difficulty sleeping, anxiety, nervousness, or depression. Before starting treatment with Daxas, inform your doctor if you have any of these symptoms or if you are taking any other medication that may increase the likelihood of these side effects. You or your caregivers should immediately inform your doctor about any change in behavior or mood and any suicidal thoughts you may have.
Children and adolescents
Do not give this medicine to children or adolescents under 18 years of age.
Other medicines and Daxas
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines, especially the following:
The effect of Daxas may be reduced if it is combined with rifampicin (a type of antibiotic) or with phenobarbital, carbamazepine, or phenytoin (medicines used to treat epilepsy). Consult your doctor.
Daxas can be combined with other medicines for the treatment of COPD, such as bronchodilators and inhaled or oral corticosteroids. Do not stop taking these medicines or reduce their dose unless your doctor tells you to.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, consult your doctor or pharmacist before using this medicine.
You should not become pregnant during treatment with this medicine and should use an effective contraceptive method during treatment, as Daxas may be harmful to the fetus.
Driving and using machines
Daxas has no or negligible influence on the ability to drive and use machines.
Daxas contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Follow exactly the instructions of administration of this medicine given by your doctor. If you are unsure, consult your doctor or pharmacist again.
Take the tablet with water. You can take it with or without food. Take it every day at the same time.
It may take several weeks for Daxas to produce its beneficial effect.
If you take more Daxas than you should
If you have taken more tablets than you should, you may experience the following symptoms: headache, nausea, diarrhea, dizziness, palpitations, confusion, mucous, and low blood pressure. Go to your doctor or pharmacist immediately. If possible, take the medicine and this leaflet with you.
If you forget to take Daxas
If you forget to take a tablet at the scheduled time, take it as soon as you remember on the same day. If you have forgotten to take it for the entire day, continue taking the normal dose the next day. Continue taking the medicine at the usual time. Do not take a double dose to make up for forgotten doses.
If you stop taking Daxas
It is essential that you continue taking Daxas for the period indicated by your doctor, even when you no longer have symptoms, to control lung function.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You may experience diarrhea, nausea, stomach pain, or headache during the first few weeks of treatment with Daxas. If these side effects do not disappear after the first few weeks of treatment, consult your doctor.
Some side effects can be serious. In clinical studies and post-marketing experience, rare cases of suicidal thoughts and behaviors (including suicide) have been reported. Inform your doctor immediately if you have any suicidal thoughts. You may also experience insomnia (frequent), anxiety (uncommon), nervousness (rare), panic attacks (rare), or depressive mood (rare).
In rare cases, allergic reactions may occur. Allergic reactions can affect the skin and, in rare cases, cause swelling of the eyelids, face, lips, and tongue, which can lead to difficulty breathing or a decrease in blood pressure and rapid heart rate. If you experience an allergic reaction, stop taking Daxas and contact your doctor immediately or go to the emergency department of the nearest hospital. Bring all your medicines and this leaflet with you and provide all the information about your current medication.
Other side effects include the following:
Common side effects(may affect up to 1 in 10 people)
Uncommon side effects(may affect up to 1 in 100 people)
Rare side effects(may affect up to 1 in 1,000 people)
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after "EXP". The expiry date is the last day of the month stated.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Daxas
The active substance is roflumilast.
Each 250 microgram tablet of Daxas contains 250 micrograms of roflumilast. The other ingredients are lactose monohydrate (see section 2 "Daxas contains lactose"), corn starch, povidone, and magnesium stearate.
Appearance and packaging
The 250 microgram tablets of Daxas are white or almost white with "D" engraved on one side and "250" on the other.
Each pack contains 28 tablets.
Marketing authorisation holder
AstraZeneca AB
SE-151 85 Södertälje
Sweden
Manufacturer
Corden Pharma GmbH
Otto-Hahn-Str.
68723 Plankstadt
Germany
You can obtain further information on this medicine from the representative of the marketing authorisation holder in your country:
België/Belgique/Belgien AstraZeneca S.A./N.V. Tel: +32 2 370 48 11 | Lietuva UAB AstraZeneca Lietuva Tel: +370 5 2660550 |
Luxembourg/Luxemburg AstraZeneca S.A./N.V. Tél/Tel: +32 2 370 48 11 | |
Ceská republika AstraZeneca Czech Republic s.r.o. Tel: +420 222 807 111 | Magyarország AstraZeneca Kft. Tel.: +36 1 883 6500 |
Danmark AstraZeneca A/S Tlf: +45 43 66 64 62 | Malta Associated Drug Co. Ltd Tel: +356 2277 8000 |
Deutschland AstraZeneca GmbH Tel: +49 40 809034100 | Nederland AstraZeneca BV Tel: +31 85 808 9900 |
Eesti AstraZeneca Tel: +372 6549 600 | Norge AstraZeneca AS Tlf: +47 21 00 64 00 |
Ελλ?δα AstraZeneca A.E. Τηλ: +30 210 6871500 | Österreich AstraZeneca Österreich GmbH Tel: +43 1 711 31 0 |
España AstraZeneca Farmacéutica Spain, S.A. Tel: +34 91 301 91 00 | Polska AstraZeneca Pharma Poland Sp. z o.o. Tel.: +48 22 245 73 00 |
Francia AstraZeneca Tél: +33 1 41 29 40 00 | Portugal AstraZeneca Produtos Farmacêuticos, Lda. Tel: +351 21 434 61 00 |
Hrvatska AstraZeneca d.o.o. Tel: +385 1 4628 000 | România AstraZeneca Pharma SRL Tel: +40 21 317 60 41 |
Ireland AstraZeneca Pharmaceuticals (Ireland) DAC Tel: +353 1609 7100 | Slovenija AstraZeneca UK Limited Tel: +386 1 51 35 600 |
Ísland Vistor hf. Sími: +354 535 7000 | Slovenská republika AstraZeneca AB, o.z. Tel: +421 2 5737 7777 |
Italia Simesa S.p.A. Tel: +39 02 00704500 | Suomi/Finland AstraZeneca Oy Puh/Tel: +358 10 23 010 |
Κ?προς Αλ?κτωρ Φαρµακευτικ? Λτδ Τηλ: +357 22490305 | Sverige AstraZeneca AB Tel: +46 8 553 26 000 |
Latvija SIA AstraZeneca Latvija Tel: +371 67377100 | Reino Unido (Northern Ireland) AstraZeneca UK Ltd Tel: +44 1582 836 836 |
Date of last revision of this leaflet
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu
The average price of DAXAS 250 micrograms tablets in October, 2025 is around 16.19 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.